Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Parkinson’s Disease Dementia

early-stage parkinsons1 - parkinson's disease59 - memory decline2 - mild cognitive impairment22 - igfbp-31 - diagnose parkinson's1 - decline in memory1 - hallucinations1 - treatment for huntington disease1 - hormone replacement therapy1 - historical hypotheses1 - biomarkers of alzheimer's disease1 - beta amyloid protein1 - eye tremor1 - dopamine-producing neurons4 - dementia in elderly1 - diagnosis of ad1 - senility1 - apolipoprotein1 - disease progression1 - blood vessels1 - brain inflammation1 - mmse1 - parkinson’s disease2 - omega-3s1 - mayo clinic1 - learning1 - hay fever1 - amyloid-β1 - great mimicker1 -